Literature DB >> 35510356

A Brief Discussion of Multi-Component Organic Solids: Key Emphasis on Co-Crystallization

Braham Dutt1, Manjusha Choudhary2, Vikas Budhwar2.   

Abstract

Co-crystallization (CCs) is a less studied phenomenon related to its applicability and reliability as it is directly related to the generation of newer multicomponent solids like co-crystals (CS), eutectic, salts or solid solutions etc. having improved physicochemical properties compared to their pure components. Further, the design and structural aspects of these multicomponent systems remain hindered compared to other techniques such as nanotechnology or solid dispersion. CC is a newer technique to modify the physicochemical as well as pharmaceutical characteristics of various drugs having issues like solubility, stability, etc. without altering or hindering their pharmacological activities. For drug delivery purpose, CC process has numerous advantages over nanotechnology and solid dispersion drug delivery techniques. CCs can modify the physicochemical properties of active pharmaceutical ingredients (API) have issues like sensitivity toward environmental hazards like temperature, moisture, or photostability issues. The availability of large numbers of conformers makes this technique favorable for the researchers in designing CS of newer and older. Although, solid dispersion and nanotechnology techniques are being utilized to a larger extent still there are some drawbacks of these techniques like stability, toxicological factors and protection from environmental factors need to be considered, while the CCs process drastically modifies the various pharmaceutical parameters without altering the pharmacological properties of API's. Salts, design of CS, their methods of preparation, and their application in various fields with special emphasis on their applicability in the pharmaceutical industry.

Entities:  

Keywords:  Co-crystals; chromophores; cocrystallization; cosmetic; eutectic; salts

Year:  2022        PMID: 35510356      PMCID: PMC9083509          DOI: 10.4274/tjps.galenos.2020.78700

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  24 in total

1.  Mechanical properties of powders for compaction and tableting: an overview.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  1999-01

2.  The salt-cocrystal continuum: the influence of crystal structure on ionization state.

Authors:  Scott L Childs; G Patrick Stahly; Aeri Park
Journal:  Mol Pharm       Date:  2007-04-27       Impact factor: 4.939

3.  Eutectics as improved pharmaceutical materials: design, properties and characterization.

Authors:  Suryanarayan Cherukuvada; Ashwini Nangia
Journal:  Chem Commun (Camb)       Date:  2014-01-28       Impact factor: 6.222

4.  Supramolecular synthon polymorphism in 2 : 1 co-crystal of 4-hydroxybenzoic acid and 2,3,5,6-tetramethylpyrazine.

Authors:  B R Sreekanth; Peddy Vishweshwar; K Vyas
Journal:  Chem Commun (Camb)       Date:  2007-06-21       Impact factor: 6.222

Review 5.  Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design.

Authors:  David J Berry; Jonathan W Steed
Journal:  Adv Drug Deliv Rev       Date:  2017-03-23       Impact factor: 15.470

6.  Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals.

Authors:  Katsuhiko Yamamoto; Shunichirou Tsutsumi; Yukihiro Ikeda
Journal:  Int J Pharm       Date:  2012-07-31       Impact factor: 5.875

7.  Generation of a co-crystal phase with novel coloristic properties via solid state grinding procedures.

Authors:  Reiko Kuroda; Yoshitane Imai; Nobuo Tajima
Journal:  Chem Commun (Camb)       Date:  2002-12-07       Impact factor: 6.222

8.  Cocrystal formation during cogrinding and storage is mediated by amorphous phase.

Authors:  Adivaraha Jayasankar; Anongnat Somwangthanaroj; Zezhi J Shao; Naír Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2006-09-19       Impact factor: 4.200

9.  Physical stability enhancement of theophylline via cocrystallization.

Authors:  Andrew V Trask; W D Sam Motherwell; William Jones
Journal:  Int J Pharm       Date:  2006-08-31       Impact factor: 5.875

10.  Co-crystal screening of diclofenac.

Authors:  Christer B Aakeröy; Angela B Grommet; John Desper
Journal:  Pharmaceutics       Date:  2011-08-31       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.